Abstract |
To evaluate the effectiveness of intravenous tiapride in preventing cephalalgia following rachiocentesis, two groups of patients were studied in a double blind trial. In group I ( tiapride), two 100 mg vials of tiapride given in a slow intravenous injection were effective in 86.7% of patients. In group II (placebo), only 46.6% of patients did not experience cephalalgia. These results were shown to be statistically significant by the Hypothesis Zo test (Zo = 2,33 for p less than 1%).
|
Authors | F X Roux, A Mallet, S Meresse |
Journal | La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris
(Sem Hop)
Vol. 59
Issue 5
Pg. 319-21
(Feb 03 1983)
France |
Vernacular Title | Prévention des céphalées survenant après rachicentèse. Essai controlé en double aveugle de l'efficacité du tiapride intraveineux. |
PMID | 6302862
(Publication Type: Clinical Trial, English Abstract, Journal Article)
|
Chemical References |
- Benzamides
- Tiapamil Hydrochloride
|
Topics |
- Adolescent
- Adult
- Aged
- Benzamides
(therapeutic use)
- Clinical Trials as Topic
- Double-Blind Method
- Female
- Headache
(etiology, prevention & control)
- Humans
- Injections, Intravenous
- Male
- Middle Aged
- Myelography
(adverse effects)
- Spinal Puncture
(adverse effects)
- Tiapamil Hydrochloride
(therapeutic use)
|